MedTrace Logo

Analgesic Efficacy of Nefopam in Patients Undergoing Kidney Transplantation

NCT01622881 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2013-08-20

No results posted yet for this study

Summary

The investigators examined the efficacy of nefopam in patients undergoing kidney transplantation.

Conditions

  • Kidney Transplantation

Interventions

DRUG

Normal saline

Normal saline 200mL : the infusion of 4mL/hr for post-operative 48 hours

DRUG

Nefopam

Nefopam 160mg (16 mL) mixed to normal saline 184 mL : the infusion of 4mL/hr for post-operative 48 hours

Sponsors & Collaborators

  • Severance Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01622881 on ClinicalTrials.gov